State Ledger
Company profile

Sarepta Therapeutics, Inc. CIK 873303

Ticker
SRPT (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, MA 02142
Fiscal year end
2025 (FY)
Market Data
Close
$16.51
Change
-$0.94
Change %
-5.39%
Volume
167,499

SRPT · trading date Oct 13, 2026 · previous close $17.45 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$2.20B
Net income
-$713.41M
Total assets
$3.35B
Total liabilities
$2.21B
Stockholders' equity
$1.14B
Cash & equivalents
$801.28M
Operating income
-$699.78M
Operating cash flow
-$205.48M
Capital expenditures
$101.97M

Fiscal year 2025, via 10-K filed 2026-03-02. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-31.8%
Net margin
-32.5%
Free cash flow
-$307.45M
Free cash flow margin
-14.0%
Liabilities / assets
65.9%
Equity / assets
34.1%
CapEx / revenue
4.6%
Operating cash flow / net income
0.29×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $2.20B -$713.41M $3.35B $2.21B $1.14B
2024 $1.90B $235.24M $3.96B $2.44B $1.53B
2023 $1.24B -$535.98M $3.26B $2.41B $859.34M
2022 $933.01M -$703.49M $3.13B $2.74B $384.95M
2021 $701.89M -$418.78M $3.15B $2.22B $928.01M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-08
Financials filed via
Form 10-K
filed 2026-03-02

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cambridge, MA 02142
215 FIRST STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies